RECTAL CANCER PATIENTS
Clinical trials for RECTAL CANCER PATIENTS explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER PATIENTS trials appear
Sign up with your email to follow new studies for RECTAL CANCER PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 'No-Cut' surgery reduce pain for rectal cancer patients?
Disease control Not yet recruitingThis study compares two ways to perform surgery for low rectal cancer. One method removes the cancerous tissue through the anus (a natural opening), while the other uses a small cut in the abdomen. Researchers want to see if the 'no-cut' method leads to fewer wound infections and…
Matched conditions: RECTAL CANCER PATIENTS
Sponsor: Istituto Clinico Humanitas • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Citrus pill joins fight against rectal cancer in new trial
Disease control Not yet recruitingThis study is testing if adding a citrus flavonoid tablet (Aimailang) to standard chemotherapy (mFOLFOX6) works better for shrinking rectal tumors before surgery. It will involve 236 patients with locally advanced rectal cancer who have high levels of a specific protein called YW…
Matched conditions: RECTAL CANCER PATIENTS
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Could a popular weight loss drug help beat rectal cancer?
Disease control Not yet recruitingThis study is testing if adding a weight loss medication (a GLP-1 receptor agonist like semaglutide) to standard pre-surgery cancer treatment improves results for overweight patients with locally advanced rectal cancer. Researchers will compare two groups: one gets the standard t…
Matched conditions: RECTAL CANCER PATIENTS
Phase: PHASE2 • Sponsor: St. James's Hospital, Ireland • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Triple-Threat attack on tough rectal cancers
Disease control Not yet recruitingThis study is testing a new approach for patients with rectal cancer that has a high risk of coming back. It combines three treatments—chemotherapy, radiation, and an immunotherapy drug—all given before surgery. The main goal is to see if this powerful combination can completely …
Matched conditions: RECTAL CANCER PATIENTS
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New drug combo aims to shrink rectal tumors before surgery
Disease control Not yet recruitingThis study is testing if adding a new two-drug immunotherapy (QL1706) to standard chemotherapy and radiation is more effective at shrinking rectal tumors before surgery. About 108 patients with locally advanced rectal cancer will be randomly assigned to receive either the standar…
Matched conditions: RECTAL CANCER PATIENTS
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC
-
Hidden toll: study investigates Women's health after rectal cancer
Knowledge-focused Not yet recruitingThis study aims to understand the gynecological and sexual side effects women experience after treatment for rectal cancer. Researchers will survey 15 women who completed treatment between 2020 and 2025 and are now in remission. The goal is to better identify and describe these o…
Matched conditions: RECTAL CANCER PATIENTS
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC